Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
338 In cholangiocarcinoma, CXCL6CXCR1/2JAK/STAT/PI3K-AKT signaling promotes tumor growth, gemcitabine resistance, and lipid metabolism reprogramming while inducing NETs that impair CD8 T-cell cytotoxicity via ROS
The storage requirements are different for each phase, and the consequences of getting them wrong are different too
Treating GLOW as an exploratory preparation of well-characterized components rather than as a validated formula is the accurate framing
Science 341 (2013)
US$ 24.19
US$ 24.74
US$ 21.72
US$ 23.29
US$ 26.17
US$ 20.59
US$ 26.20
US$ 29.47
US$ 26.78
